Physician profile
Qun Ming Zhang
NPI 1295980399
$28,215.11
in general payments reported to CMS, 2019-2025
73 companies · $6,535 in 2025
The $6,535 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,703 · 2022: $4,836 · 2023: $5,748 · 2024: $7,393 · 2025: $6,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,499.48 |
| Education | $177.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,060.64 | 2021-2025 | |
| Biogen, INC. | $1,711.40 | 2021-2025 | Vumerity, Tysabri, Avonex |
| Ucb, INC. | $1,708.44 | 2021-2025 | Briviact, Nayzilam, Rystiggo |
| Mdd US Operations, LLC | $1,705.44 | 2022-2025 | Apokyn, Apokyn |
| Jazz Pharmaceuticals INC. | $1,454.88 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,172.83 | 2021-2025 | |
| Lilly USA, LLC | $1,046.74 | 2021-2025 | Kisunla, Emgality, Amyvid |
| Eisai INC. | $940.36 | 2021-2025 | |
| Harmony Biosciences LLC | $930.49 | 2022-2025 | Wakix |
| Neurocrine Biosciences, INC. | $920.83 | 2021-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $874.97 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $787.25 | 2021-2025 | Uplizna, Aimovig |
| Catalyst Pharmaceuticals, INC. | $734.79 | 2021-2025 | Fycompa, Firdapse |
| Alexion Pharmaceuticals, INC. | $691.92 | 2021-2025 | Ultomiris, Soliris |
| Pfizer INC. | $611.09 | 2024-2025 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $592.82 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $585.58 | 2021-2025 | Ponvory, Hetlioz, Fanapt |
| Teva Pharmaceuticals USA, INC. | $542.46 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alnylam Pharmaceuticals INC. | $528.97 | 2021-2024 | Onpattro |
| Lundbeck LLC | $467.29 | 2021-2025 | Vyepti |
| Genentech USA, INC. | $414.41 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Banner Life Sciences, LLC | $412.49 | 2022-2024 | |
| Celgene Corporation | $405.54 | 2022-2025 | Zeposia |
| Tg Therapeutics, INC. | $369.15 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $341.16 | 2021-2025 | Nuplazid, Daybue |
| Amneal Pharmaceuticals LLC | $297.89 | 2021-2025 | Rytary, Crexont, Ongentys |
| Biohaven Pharmaceutical Holding Company LTD. | $276.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $268.31 | 2021-2023 | Ponvory |
| Takeda Pharmaceuticals U.S.A., INC. | $262.82 | 2022-2025 | Hyqvia, Gammagard |
| Genzyme Corporation | $235.70 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $224.40 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $201.24 | 2021 | |
| Springworks Therapeutics, INC. | $193.88 | 2024-2025 | Gomekli |
| Acorda Therapeutics, INC | $193.23 | 2021-2023 | Inbrija, Ampyra |
| Sumitomo Pharma America, INC. | $193.21 | 2023-2024 | Aptiom |
| Emd Serono, INC. | $176.31 | 2022-2023 | Mavenclad |
| Horizon Therapeutics Plc | $171.72 | 2022-2023 | Uplizna |
| Grifols USA, LLC | $168.23 | 2023-2025 | Gamunex-C |
| Neurelis, INC. | $161.65 | 2022-2025 | Valtoco |
| Allergan, INC. | $153.07 | 2021-2022 | |
| Livanova USA, INC. | $151.47 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Idorsia Pharmaceuticals US INC | $149.38 | 2022-2023 | Quviviq |
| Tanabe Pharma America, INC. | $143.12 | 2021-2025 | Radicava |
| Mallinckrodt Hospital Products INC. | $121.65 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $102.66 | 2023-2025 | Rexulti, Nuedexta |
| Upsher-Smith Laboratories LLC | $101.50 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $99.97 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $87.53 | 2024-2025 | Lumryz |
| Csl Behring | $84.42 | 2021-2025 | Hizentra |
| Axsome Therapeutics, INC. | $83.14 | 2023-2025 | Symbravo, Sunosi |
| Avanir Pharmaceuticals, INC. | $81.62 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $74.78 | 2025 | Bafiertam |
| Aucta Pharmaceuticals, INC. | $68.86 | 2024-2025 | Motpoly Xr |
| Kyowa Kirin, INC. | $67.72 | 2022-2023 | Nourianz |
| Merz Pharmaceuticals, LLC | $66.82 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $62.03 | 2022 | |
| Aquestive Therapeutics, INC. | $55.46 | 2024 | |
| Octapharma USA, INC. | $53.03 | 2024-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Abbott Laboratories | $50.23 | 2021 | |
| Impel Pharmaceuticals INC. | $49.33 | 2023 | Trudhesa |
| Avion Pharmaceuticals | $41.28 | 2022-2023 | Dhivy |
| Collegium Pharmaceutical, INC. | $30.99 | 2022 | |
| Almatica Pharma LLC | $27.98 | 2021 | |
| Microtransponder, INC. | $24.88 | 2024 | |
| Azurity Pharmaceuticals, INC. | $24.34 | 2025 | Horizant |
| Ipsen Biopharmaceuticals, INC | $18.56 | 2025 | Dysport |
| Cala Health, INC. | $18.48 | 2025 | Cala Kiq |
| Arbor Pharmaceuticals, INC. | $18.09 | 2021 | |
| Adamas Pharmaceuticals, INC. | $17.26 | 2021 | |
| Medtronic, INC. | $14.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.27 | 2024 | |
| Aprecia Pharmaceuticals, LLC | $11.86 | 2022 | |
| Corium, LLC | $8.88 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qun Ming Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.